These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32694701)

  • 41. Extracellular Flux Assays to Determine Oxidative Phosphorylation and Glycolysis in Chronic Lymphocytic Leukemia Cells.
    Vangapandu HV; Gandhi V
    Methods Mol Biol; 2019; 1881():121-128. PubMed ID: 30350202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolomic and BH3 profiling of esophageal cancers: novel assessment methods for precision therapy.
    Taylor Ripley R; Surman DR; Diggs LP; Trepel JB; Lee MJ; Ryan J; Davis JL; Steinberg SM; Hernandez JM; Hoang C; Kenney CM; Bond CD; Kunst TF; Letai A; Schrump DS
    BMC Gastroenterol; 2018 Jun; 18(1):94. PubMed ID: 29933761
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nrf2 promotes oesophageal cancer cell proliferation via metabolic reprogramming and detoxification of reactive oxygen species.
    Kitano Y; Baba Y; Nakagawa S; Miyake K; Iwatsuki M; Ishimoto T; Yamashita YI; Yoshida N; Watanabe M; Nakao M; Baba H
    J Pathol; 2018 Mar; 244(3):346-357. PubMed ID: 29243822
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An Integrative "Omics" Approach, for Identification of Bona Fides PLK1 Associated Biomarker in Esophageal Adenocarcinoma.
    Bibi N; Rashid S; Nicholson J; Malloy M; O'Neill R; Blake D; Hupp T
    Curr Cancer Drug Targets; 2019; 19(9):742-755. PubMed ID: 30747067
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of neoadjuvant chemoradiotherapy on angiogenesis in oesophageal cancer.
    McDonnell CO; Bouchier-Hayes DJ; Toomey D; Foley D; Kay EW; Leen E; Walsh TN
    Br J Surg; 2003 Nov; 90(11):1373-8. PubMed ID: 14598417
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Using Seahorse Machine to Measure OCR and ECAR in Cancer Cells.
    Zhang J; Zhang Q
    Methods Mol Biol; 2019; 1928():353-363. PubMed ID: 30725464
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cooperation between chemotherapy and immune checkpoint blockade to enhance anti-tumour T cell immunity in oesophageal adenocarcinoma.
    Davern M; Donlon NE; O' Connell F; Sheppard AD; Hayes C; King R; Temperley H; Butler C; Bhardwaj A; Moore J; Bracken-Clarke D; Donohoe C; Ravi N; Reynolds JV; Maher SG; Conroy MJ; Lysaght J
    Transl Oncol; 2022 Jun; 20():101406. PubMed ID: 35366537
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gene regulatory networking reveals the molecular cue to lysophosphatidic acid-induced metabolic adaptations in ovarian cancer cells.
    Ray U; Roy Chowdhury S; Vasudevan M; Bankar K; Roychoudhury S; Roy SS
    Mol Oncol; 2017 May; 11(5):491-516. PubMed ID: 28236660
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluating the Metabolic Alterations in Pancreatic Cancer.
    Dasgupta A; Shukla SK; Gunda V; King RJ; Singh PK
    Methods Mol Biol; 2019; 1882():221-228. PubMed ID: 30378058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1.
    Garcia E; Hayden A; Birts C; Britton E; Cowie A; Pickard K; Mellone M; Choh C; Derouet M; Duriez P; Noble F; White MJ; Primrose JN; Strefford JC; Rose-Zerilli M; Thomas GJ; Ang Y; Sharrocks AD; Fitzgerald RC; Underwood TJ;
    Sci Rep; 2016 Sep; 6():32417. PubMed ID: 27600491
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma.
    Fisher OM; Levert-Mignon AJ; Lord SJ; Lee-Ng KK; Botelho NK; Falkenback D; Thomas ML; Bobryshev YV; Whiteman DC; Brown DA; Breit SN; Lord RV
    Br J Cancer; 2015 Apr; 112(8):1384-91. PubMed ID: 25867265
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Visceral obesity stimulates anaphase bridge formation and spindle assembly checkpoint dysregulation in radioresistant oesophageal adenocarcinoma.
    Mongan AM; Lynam-Lennon N; Casey R; Maher S; Pidgeon G; Reynolds JV; O'Sullivan J
    Clin Transl Oncol; 2016 Jun; 18(6):632-40. PubMed ID: 26474871
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glycine-extended gastrin inhibits apoptosis in Barrett's oesophageal and oesophageal adenocarcinoma cells through JAK2/STAT3 activation.
    Beales IL; Ogunwobi OO
    J Mol Endocrinol; 2009 Apr; 42(4):305-18. PubMed ID: 19153190
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of biological markers of epithelial to mesenchymal transition in oesophageal adenocarcinoma, an immunohistochemical study.
    Prins MJ; Ruurda JP; Lolkema MP; Sitarz R; Ten Kate FJ; van Hillegersberg R
    J Clin Pathol; 2015 Jul; 68(7):529-35. PubMed ID: 25855799
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ginsenoside Rh4 suppresses aerobic glycolysis and the expression of PD-L1 via targeting AKT in esophageal cancer.
    Deng X; Zhao J; Qu L; Duan Z; Fu R; Zhu C; Fan D
    Biochem Pharmacol; 2020 Aug; 178():114038. PubMed ID: 32422139
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dietary inflammatory index and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study.
    Shivappa N; Hebert JR; Anderson LA; Shrubsole MJ; Murray LJ; Getty LB; Coleman HG
    Br J Nutr; 2017 May; 117(9):1323-1331. PubMed ID: 28571591
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Repression of oxidative phosphorylation sensitizes leukemia cell lines to cytarabine.
    Yucel B; Sonmez M
    Hematology; 2018 Jul; 23(6):330-336. PubMed ID: 29139328
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interleukin-17A promotes esophageal adenocarcinoma cell invasiveness through ROS-dependent, NF-κB-mediated MMP-2/9 activation.
    Liu D; Zhang R; Wu J; Pu Y; Yin X; Cheng Y; Wu J; Feng C; Luo Y; Zhang J
    Oncol Rep; 2017 Mar; 37(3):1779-1785. PubMed ID: 28184939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-resolution spatiotemporal pH
    Blancke Soares A; Meier R; Liebsch G; Schwenk-Zieger S; Kirmaier ME; Theurich S; Widmann M; Canis M; Gires O; Haubner F
    Cancer Metab; 2021 May; 9(1):21. PubMed ID: 33947450
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of surveillance for Barrett's oesophagus on tumour stage and survival of patients with neoplastic progression.
    Kastelein F; van Olphen SH; Steyerberg EW; Spaander MC; Bruno MJ;
    Gut; 2016 Apr; 65(4):548-54. PubMed ID: 25903690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.